# EDGAR Filing Document

**Accession Number:** 0002008748
**File Stem:** 0000930413-25-003070
**Filing Date:** 2025-9
**Character Count:** 9588
**Document Hash:** 0c221722d8091ec64da2b7735760a649
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000930413-25-003070.hdr.sgml**: 20250926

**ACCESSION NUMBER**: 0000930413-25-003070

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20250922

**ITEM INFORMATION**: Unregistered Sales of Equity Securities

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Other Events

**FILED AS OF DATE**: 20250926

**DATE AS OF CHANGE**: 20250926

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Lord Abbett Private Credit Fund
- **CENTRAL INDEX KEY:** 0002008748

**ORGANIZATION NAME:**
- **EIN:** 934670837
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 814-01764
- **FILM NUMBER:** 251348937

**BUSINESS ADDRESS:**
- **STREET 1:** C/O LORD, ABBETT & CO. LLC
- **STREET 2:** 30 HUDSON STREET
- **CITY:** JERSEY CITY
- **STATE:** NJ
- **ZIP:** 07302
- **BUSINESS PHONE:** 888-522-2388

**MAIL ADDRESS:**
- **STREET 1:** C/O LORD, ABBETT & CO. LLC
- **STREET 2:** 30 HUDSON STREET
- **CITY:** JERSEY CITY
- **STATE:** NJ
- **ZIP:** 07302

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Lord Abbett Private Credit Fund 1, LP
- **DATE OF NAME CHANGE:** 20240118

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, DC 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the**

**Securities Exchange Act of 1934**

Date of report (Date of earliest event reported): **September 22, 2025**

**Lord Abbett Private Credit Fund**

(Exact name of Registrant as Specified in Its Charter)

---

| | | |
|:---|:---|:---|
| **DELAWARE**<br> (State or Other Jurisdiction<br> of Incorporation) | **814-01764**<br> (Commission<br> File Number) | **93-4670837**<br> (IRS Employer<br> Identification No.) |

---

---

| | |
|:---|:---|
| **30 Hudson Street<br> Jersey City, New Jersey** | **07302** |
| (Address of Principal Executive Offices) | (Zip Code) |

---

Registrant's telephone number, including area code: **(888) 522-2388**

**N/A**

(Former Name or Former Address, if Changed Since Last Report)

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| N/A | N/A | N/A |

---

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (*see* General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 3.02. Unregistered Sales of Equity Securities.**

As of September 2, 2025, Lord Abbett Private Credit Fund ("we", the "Company" or the "Fund"), issued and sold approximately 674,414 of the Company's common shares of beneficial interest (the "Common Shares") for an aggregate offering price of approximately $17.0 million, reflecting a purchase price of $25.17 per Common Share (with the final number of Common Shares being determined on September 22, 2025).

The offer and sale of Common Shares was made pursuant to subscription agreements entered into by the Company and its shareholders. The issuance of the Common Shares is exempt from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"), provided by Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder. The Company relied, in part, upon representations from the shareholders in the subscription agreements that each shareholder was an accredited investor as defined in Regulation D under the Securities Act.

**Item 7.01. Regulation FD Disclosure.**

**Company's Portfolio:**

As of August 31, 2025, the Company had made loans to 30 portfolio companies and held one investment in a joint venture, with an aggregate loan commitment amount of approximately $1,017 million and par value of approximately $817 million. The portfolio consists of 94% first lien debt investments and 6% investment in a joint venture, based on par value or in the case of investments in a joint venture, cost. As of August 31, 2025, 100% of the debt investments, based on par value, in the Company's portfolio were at floating rates. As of August 31, 2025, 98% of the Company's total loan commitments were in private senior secured loans. The following table presents information concerning portfolio companies to which the Company has made loans.

---

| |
|:---|
| **Portfolio Company Metrics<sup>(1)</sup>:** |
| Median 12-month EBITDA: $77 million<sup>(2)</sup> |
| Weighted average net leverage: 4.7x<sup>(2)(3)</sup> |
| Weighted average loan to value: 41%<sup>(2)(4)</sup> |
| Weighted average interest coverage: 2.2x<sup>(2)(5)</sup> |
| Weighted average yield on debt investments, at cost: 9.8%<sup>(6)</sup> |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) Amounts
 were derived from the most recently available financial statements provided by portfolio
 companies which have not been independently verified by us and may reflect a normalized
 or adjusted amount. Such amounts have not been independently estimated by us, and accordingly,
 we take no responsibility for such numbers and make no representation or warranty in
 respect of this information.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) Metrics
 exclude one liquid loan. Metrics also exclude one recurring revenue investment, which
 are investments in portfolio companies in which the Company lends based on a multiple
 of recurring revenue generated by the portfolio company and not based on a multiple of
 EBITDA. Weighted average metrics are calculated as a percentage of funded par value of
 debt investments.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) Net
 leverage is the ratio of total senior debt minus cash divided by EBITDA and taking into
 account leverage through the tranche to which the Company is a lender.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) Calculated
 using total senior debt minus cash divided by total enterprise value estimated by the
 private equity sponsor or market comparables.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5) Interest
 coverage for a particular portfolio company is calculated by taking EBITDA and dividing
 by annualized latest reported interest expense.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(6) Computed
 as (a) the annual stated spread, plus reference rate, as applicable, plus the annual
 accretion of discounts, plus the annual unused fees, as applicable on debt securities
 divided by (b) total debt investments at cost included in such securities. Actual yields
 earned over the life of each investment could differ materially from the yields presented
 herein.

During the period from August 1, 2025, through August 31, 2025, the Company had new investment commitments of approximately $25.8 million.

The table below shows the Company's investment activity during the period August 1, 2025, through August 31, 2025. Amounts shown for commitment amount and par value are as of August 31, 2025:

---

| | | |
|:---|:---|:---|
| **Issuer** | **Commitment Amount<br> ($ in millions)** | **Par Amount<br> ($ in millions)** |
| Flourish Research Acquisition, LLC | $7.8 | $0.0 |
| CP Atlas Buyer, Inc. | $14.4 | $14.4 |
| Security 101 | $3.6 | $3.6 |
| **Total** | **$25.8** | **$18.0** |

---

**Item 8.01. Other Events.**

**Distribution:**

On September 22, 2025, the Company declared a distribution of $0.22 per share to shareholders of record on September 30, 2025 to be payable on October 28, 2025.

**Net Asset Value**

As of August 31, 2025, the Company's aggregate net asset value ("NAV") was approximately $401 million. The NAV per share of Common Shares as of August 31, 2025, as determined in accordance with the Company's valuation policy, was $25.17 per Common Share.

Final results related to all of the above information and other information may differ materially as a result of the completion of the Company's financial closing procedures, which will occur between the date hereof and the completion of the financial statements and the filing of the Company's quarterly report on Form 10-Q for the quarter ending September 30, 2025.

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  |  | **LORD ABBETT PRIVATE CREDIT FUND** |
| Date: September 26, 2025 | By: | /s/ Salvatore Dona |
|  | Name: | Salvatore Dona |
|  | Title: | Chief Financial Officer |

---